AKT1 and cancer: For instance, Trichostatin A, a drug that influences miR-204 expression, can increase the expression of ERα and, alongside Tamoxifen (TAM), enhance cancer cell sensitivity to treatment by reducing the activity of pathways such as AKT/mTOR, which are involved in cancer cell survival.